
The price history is unavailable right now.
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
Nothing in its numbers stands out right now.
No weak spot in its numbers right now.
Loading…
In 11 copy portfolios. See which with Premium
No company summary is available right now.
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in RevenueThe Motley Fool · 2 h ago
J&J to Boost Ophthalmology Pipeline With $2.2B Ollin AcquisitionYahoo Finance · 7 h ago
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat RevenueThe Motley Fool · 9 h ago